11.05.2025
Illumination in the cochlea
Frankfurter Allgemeine Sonntagszeitung reports on hearing research in Göttingen: A new dimension of hearing for those who are deaf or extremely hard of hearing. A large research network in Göttingen around MBExC member Tobias Moser is developing a high-tech hearing aid that uses light and genetic engineering to enable hearing.
07.05.2025
Oskar Lapp Research Award 2025 for cardiovascular research goes to Göttingen
Scientists from the ‘Molecular Pharmacology’ working group at the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen (UMG) have been awarded this year’s Oskar Lapp Research Award. Dr. Funsho Fakuade, postdoctoral researcher, and medical students Dominik Hubricht and Vanessa Möller were presented with the award at the
06.05.2025
Insights into the connections between “Heart & Brain”
Within the framework of the Research Training Group (RTG) 2824 “Heart & Brain diseases: integrative research across organs”, MBExC member Tobias Brügmann and scientists from the RTG2824 had the exciting opportunity to show students of the Otto-Hahn-Gymnasium (OHG) in Göttingen the fascinating connections between the heart and brain. The session
30.04.2025
Ovo Labs secures 4 million pounds in start-up capital
Founded in January 2025, Ovo Labs is a biotech company that has emerged from the Max Planck Institute (MPI) for Multidisciplinary Sciences in Göttingen (Germany). The company develops novel therapeutics to improve the quality of human eggs. The active compounds are designed to help women remain fertile for longer and
24.04.2025
World Day for Laboratory Animals
110 scientists clearly affirm their commitment to animal research: “We conduct animal experiments!” On the occasion of the World Day for Laboratory Animals on 24 April 2025, 110 leading scientists from Germany (including MBExC members) are publicly affirming their commitment to animal research. Under the joint statement “We conduct
07.04.2025
Pioneering partnership shaping the future of regenerative cardiac medicine
With the signing of an equity agreement on April 2, 2025, biotech pioneers Repairon GmbH and life science investor Bioventure Management GmbH, both based in Göttingen, have entered into a strategic partnership with the potential to fundamentally change the treatment of heart failure worldwide. Bioventure is investing in Repairon –
03.04.2025
Nadja Simeth-Crespi appointed as W2 professor of Molecular Labeling Chemistry
Congratulations to MBExC member Nadja Simeth-Crespi on her appointment as W2 Professor of Molecular Labeling Chemistry at the University of Göttingen! Prof. Simeth-Crespi and her team’s research intersects the boundaries of bioorganic and photochemistry, with a focus on the design of smart drugs, biochemical probes and labels, as well
28.03.2025
Artificial neurons organize themselves
Göttingen research team constructs network of self-learning infomorphic neurons Novel artificial neurons learn independently and are more strongly modeled on their biological counterparts. A team of researchers from the Göttingen Campus Institute for Dynamics of Biological Networks (CIDBN) at the University of Göttingen and the Max Planck Institute for
25.03.2025
Thomas Frank receives project funding from the Schram Foundation
MBExC member Dr. Thomas Frank has received €360,000 in project funding over three years from the Schram Foundation. His project “Cellular mechanisms and brain-wide circuits of chemosensory valence coding” uses zebrafish as a model organism to investigate how the brain processes sensory information, such as odors, across different levels of
25.03.2025
Public inaugural lecture by Prof. Dr. Urs Valentin Nägerl
Shadows and glimpses of light: structure and function of the interstitial space in the brain MBExC member Prof. Dr. Urs Valentin Nägerl has held the University Professorship of Anatomy and Cell Biology at the University Medical Center Göttingen (UMG) since September 1, 2024 and heads the Institute of Anatomy